Success of Systemic Methotrexate Administration Versus Laparoscopic Salpingostomy in Ectopic Pregnancy

Authors

  • Özlem Gün Eryılmaz Zekai Tahir Burak Women’s Health Research and Education Hospital Department of Endoscopic Surgery, Ankara
  • Özlem Moraloğlu Zekai Tahir Burak Women’s Health Research and Education Hospital Department of Endoscopic Surgery, Ankara
  • Kerem Doğa Seçkin Zekai Tahir Burak Women’s Health Research and Education Hospital Department of Endoscopic Surgery, Ankara
  • Mahmut İlkin Yeral Zekai Tahir Burak Women’s Health Research and Education Hospital Department of Endoscopic Surgery, Ankara
  • Ayhan Sucak Zekai Tahir Burak Women’s Health Research and Education Hospital Department of Endoscopic Surgery, Ankara
  • Hacer Cavidan Gülerman Zekai Tahir Burak Women’s Health Research and Education Hospital Department of Endoscopic Surgery, Ankara

Keywords:

Tubal ectopic pregnancy, Medical treatment, Single dose methotrexate, Laparoscopic surgery.

Abstract

OBJECTIVE: In this study, we tried to compare the efficacies of laparoscopic salpingostomy and medication with a single dose of Methotrexate (50mg/m2) in ectopic pregnancy to determine the differences between the two methods in terms of treatment outcomes.
STUDY DESIGN: In this study, 64 patients with ectopic pregnancy who had been administered an MTX therapy between August 2007 and July 2010 (Group A) were compared with another 64 patients with matching ages who had undergone a laparoscopic salpingostomy (Group B). The two groups were compared in terms of age, gravida, parity, initial hCG value, hCG measured at the time of being discharged from the hospital, hCG values checked a week later and the number of hospitalization days. The number of repeating doses and the rate of undergoing a laparoscopy salpingostomy were calculated in patients receiving MTX.
RESULTS: The hCG values of the patients in the MTX and laparoscopy groups respectively were as follows: Initial hCG measurement; 670.5±1027.5 vs. 5511.3± 7293.0 (p=0.0001), hCG measured at the time of discharge; 352.3±627.0 vs. 869.7±599.1 (p=0.016), and hCG value after a week; 292.5±617.4 vs 864.1±1531.8 (p=0.023). The difference in the number of hospitalization days between the two groups came out to be significant; 2.4±4.2 for the MTX group and 1.3±1.6 for the laparoscopy group with p=0.01. Repetition of the dose became necessary in 14.1% (9/64) of the patients receiving medical treatment (MTX) as their hCG values did not decrease. Success was achieved in treating 4.7% (6/64) of
these patients after the second dose and the rate of undergoing a laparoscopic salpingostomy due to MTX failure was calculated to be 4.6%.
CONCLUSION: We found in this study that MTX used as a medical treatment in ectopic pregnancy was as successful as a laparoscopic salpingostomy. MTX failure can be minimized by firmly determining the criteria for the patients who will be given a medical treatment.

Downloads

Download data is not yet available.

Downloads

Published

2011-12-10

How to Cite

1.
Eryılmaz Özlem G, Moraloğlu Özlem, Seçkin KD, Yeral M İlkin, Sucak A, Gülerman HC. Success of Systemic Methotrexate Administration Versus Laparoscopic Salpingostomy in Ectopic Pregnancy. Gynecol Obstet Reprod Med [Internet]. 2011Dec.10 [cited 2024Nov.22];17(3):151-4. Available from: https://gorm.com.tr/index.php/GORM/article/view/313

Issue

Vol. 17 No. 3 (2011)

Section

Reproductive Medicine: Endocrinology and Infertility

License

CC BY

All the articles published in GORM are licensed with "Creative Commons Attribution 4.0 License (CC BY 4.0)". This license entitles all parties to copy, share and redistribute all the articles, data sets, figures and supplementary files published in this journal in data mining, search engines, web sites, blogs and other digital platforms under the condition of providing references.